Summary
Thermo Fisher Scientific Inc. (TMO) has filed an 8-K report on July 23, 2025, to announce its financial results for the fiscal quarter ended June 28, 2025. This filing primarily serves to furnish the accompanying press release, which contains the detailed financial performance of the company for the period. Investors should refer to the press release (Exhibit 99.1) for specific figures related to revenue, profitability, and any forward-looking guidance issued by the company. The information provided in this 8-K is crucial for understanding TMO's operational performance in the second quarter of 2025. While the 8-K itself does not contain the financial statements, it directs investors to the press release for the results of operations and financial condition. Investors are advised to carefully review the press release for key metrics, segment performance, and management's commentary on the business environment and outlook.
Key Highlights
- 1Thermo Fisher Scientific Inc. (TMO) announced financial results for the fiscal quarter ended June 28, 2025.
- 2The results were disclosed via a press release furnished as Exhibit 99.1 to the 8-K filing.
- 3The filing date was July 23, 2025, with an event date of July 22, 2025.
- 4Investors are directed to the press release for detailed financial performance data and commentary.
- 5The report includes the standard disclaimer regarding information not being deemed 'filed' for certain regulatory purposes.
- 6The filing also notes the inclusion of a Cover Page Interactive Data File.